Actovegin by Takeda is a deproteinized hemoderivative of calf blood - a purified biological extract without protein components. It is one of the most widely used injectable preparations in neurological and metabolic practice across Europe and Russia.
Available variants (select above):
Composition
Why Actovegin is used
Mechanism
The hemoderivative increases cellular glucose uptake and utilization independent of insulin, improves ATP metabolism and oxygen transport at the tissue level. In simple terms: it helps cells survive and recover under ischemia and energy deficit.
Administration
Product features
Contraindications
Hypersensitivity to Actovegin or its components. Pregnancy and breastfeeding - only under medical supervision. Not for children without prescription.
FAQ
For classic 10-day IM courses the 2 ml × 25 pack is the common format. For IV infusion protocols the 10 ml × 5 pack covers the standard start. The 5 ml × 5 pack suits mid-dose regimens. Your physician's prescription determines the choice.
No. Unlike lyophilized products (e.g., Cortexin), Actovegin injectable solution is ready to use.
Both are cerebral-support injectables but different classes: Actovegin is a blood-derived metabolic enhancer (glucose/oxygen utilization), Cortexin is a peptide nootropic from cortical tissue. In practice they are often used in complementary treatment schemes.
Actovegin is registered and widely used in Europe (original Takeda), Russia, CIS and Asia. It is not FDA-approved in the USA - that is a regulatory difference, not a quality one.
No. Use the entire ampoule contents immediately after opening; ampoules are single-use. Store the unopened box below 25 C, protected from light.
Ask a question or inquire about delivery to your country





